The clinical relevance of cognitive impairment in REM sleep behavior disorder
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
REM sleep behavior disorder (RBD) is a REM sleep parasomnia characterized by complex and often violent behaviors, potentially harmful for bed partners and patients themselves.1 RBD without signs of neurologic disorders is conventionally called “idiopathic” RBD (iRBD). However, more than 80% of patients with iRBD eventually develop a neurodegenerative disease, mostly a synucleinopathy.2 According to the largest longitudinal study to date, among the patients with iRBD who develop a neurodegenerative disease, 42% convert to Parkinson disease (PD), 50.5% to dementia with Lewy bodies (DLB), and 7.5% to multiple system atrophy.3 Conversely, 42.3% of patients with PD exhibit RBD,4 and the presence of RBD is associated with cognitive impairment in PD,5 thus identifying a malignant PD subtype as opposed to a more benign “mainly motor” phenotype.6 Moreover, considering its high prevalence in DLB, RBD has been included in the core clinical features of the revised DLB diagnostic criteria.7 Thus, there is an increasingly clear association between cognitive impairment and RBD.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 914
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a centuryD.O. Claassen, K.A. Josephs, J.E. Ahlskog et al.Neurology, July 28, 2010 -
Articles
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementiaM. Vendette, J. -F. Gagnon, A. Décary et al.Neurology, November 05, 2007 -
Article
Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorderShady Rahayel, Ronald B. Postuma, Jacques Montplaisir et al.Neurology, April 18, 2018 -
Views & Reviews
Idiopathic REM sleep behavior disorderToward a better nosologic definitionMaria Livia Fantini, Luigi Ferini-Strambi, Jacques Montplaisir et al.Neurology, March 07, 2005